Potential therapeutic strategies to target gut microbiota in hepatocellular carcinoma

Amedeo Amedei^{1

2}

Affiliations

¹ Department of Experimental and Clinical Medicine, University of Florence, Florence, Italy.
² Sod of Interdisciplinary Internal Medicine, Azienda Ospedaliera Universitaria Careggi (AOUC), University of Florence, Florence, Italy.

Editorial

Amedeo Amedei. Hepatobiliary Surg Nutr. 2019 Oct.

. 2019 Oct;8(5):527-529.

doi: 10.21037/hbsn.2019.09.04.

Amedeo Amedei^{1

2}

¹ Department of Experimental and Clinical Medicine, University of Florence, Florence, Italy.
² Sod of Interdisciplinary Internal Medicine, Azienda Ospedaliera Universitaria Careggi (AOUC), University of Florence, Florence, Italy.

No abstract available

Conflict of interest statement

Conflicts of Interest: The author has no conflicts of interest to declare.

Targeting gut microbiota in hepatocellular carcinoma: probiotics as a novel therapy.
Wan MLY, El-Nezami H. Wan MLY, et al. Hepatobiliary Surg Nutr. 2018 Feb;7(1):11-20. doi: 10.21037/hbsn.2017.12.07. Hepatobiliary Surg Nutr. 2018. PMID: 29531939 Free PMC article. Review.

1. O'Hara AM, Shanahan F. The gut flora as a forgotten organ. EMBO Rep 2006;7:688-93. 10.1038/sj.embor.7400731 - DOI - PMC - PubMed
1. Kho ZY, Lal SK. The Human Gut Microbiome - A Potential Controller of Wellness and Disease. Front Microbiol 2018;9:1835. 10.3389/fmicb.2018.01835 - DOI - PMC - PubMed
1. Zuo T, Ng SC. The Gut Microbiota in the Pathogenesis and Therapeutics of Inflammatory Bowel Disease. Front Microbiol 2018;9:2247. 10.3389/fmicb.2018.02247 - DOI - PMC - PubMed
1. Al Khodor S, Shatat IF. Gut microbiome and kidney disease: a bidirectional relationship. Pediatr Nephrol 2017;32:921-31. 10.1007/s00467-016-3392-7 - DOI - PMC - PubMed
1. Baothman OA, Zamzami MA, Taher I, Abubaker J, Abu-Farha M. The role of Gut Microbiota in the development of obesity and Diabetes. Lipids Health Dis 2016;15:108. 10.1186/s12944-016-0278-4 - DOI - PMC - PubMed